Detalhe da pesquisa
1.
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
Am J Transplant
; 22(11): 2675-2681, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713984
2.
Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study.
Am J Transplant
; 21(1): 329-337, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741096
3.
In-depth virological assessment of kidney transplant recipients with COVID-19.
Am J Transplant
; 20(11): 3162-3172, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777130
4.
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant.
Kidney Int
; 102(2): 442-444, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618094
5.
Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
Transpl Int
; 30(1): 29-40, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27678382
6.
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
Kidney Int
; 99(6): 1487-1489, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33775674
7.
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
Kidney Int
; 99(6): 1498-1500, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887315
8.
SARS-CoV-2 viral dynamics in immunocompromised patients.
Am J Transplant
; 21(4): 1667-1669, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33048424
9.
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.
Am J Transplant
; 21(6): 2307-2310, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33370503
10.
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.
Am J Transplant
; 21(11): 3808-3810, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254431
11.
Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study.
BMC Nephrol
; 17(1): 58, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27278793
12.
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
Kidney Int
; 98(2): 508-509, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32505467
13.
Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
Chest
; 165(3): 507-520, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839586
14.
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
J Pers Med
; 12(7)2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887604
15.
Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation.
Kidney Int Rep
; 7(5): 983-992, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155848
16.
Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients.
Kidney Int Rep
; 7(6): 1241-1247, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35372734
17.
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Sci Transl Med
; 14(636): eabl6141, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103481
18.
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.
Transplantation
; 105(10): 2165-2169, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756547
19.
Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort.
Transplantation
; 104(10): 2148-2157, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895344
20.
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Transplantation
; 107(8): e215-e218, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340538